Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Becker

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2016
Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerQurrat Mehmood, Alexander Sun, Nathan Becker, et al.
Genome Medicine|July 15, 2025
Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroupsEnze Liu, Oumaima Jaouadi, Riya Sharma, et al.
Nature Communications|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2016
Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerQurrat Mehmood, Alexander Sun, Nathan Becker, et al.
Genome Medicine|July 15, 2025
Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroupsEnze Liu, Oumaima Jaouadi, Riya Sharma, et al.
Nature Communications|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Pageof 4